Form 4: Phibro Animal Health CEO Reports Stock Transaction
Insider Transaction (Form 4)
Daniel M Bendheim, President and CEO and a Director of Phibro Animal Health Corp, reported a transaction in 486 shares of common stock on August 4, 2026.
Summary
- Other acquisition/disposition: disposed of 486 Class A Common Stock at $36.60 ($17,787) on August 4, 2026; holds 3,478 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Daniel M Bendheim — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-04 | Other acquisition/disposition | Class A Common Stock | 486 | $37 | $17.8K | 3,478 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-04 | Other acquisition/disposition (486 shares) |
Keywords
insider transaction, Form 4, PAHC, PHIBRO ANIMAL HEALTH CORP, neutral, Daniel M Bendheim
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.